|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.00 INR | -0.51% |
|
-5.71% | -30.76% |
| Market Cap | 98Cr 1.01Cr 88.56L 81.72L 75.32L 1.42Cr 1.45Cr 9.77Cr 3.84Cr 48Cr 3.81Cr 3.72Cr 164.53Cr | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 134.42Cr 1.4Cr 1.22Cr 1.13Cr 1.04Cr 1.96Cr 2Cr 13Cr 5.29Cr 66Cr 5.24Cr 5.13Cr 226.62Cr | EV / Sales 2024 |
1,23,82,225x | EV / Sales 2025 | 1,42,98,457x |
| Free-Float |
21.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.51% | ||
| 1 week | -5.71% | ||
| Current month | -15.32% | ||
| 1 month | +2.23% | ||
| 3 months | +5.06% | ||
| 6 months | -30.23% | ||
| Current year | -30.76% |
| 1 week | 32.35 |  | 36.9 |
| 1 month | 31.5 | | 41.9 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 70 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 05/12/2025 | |
| Director/Board Member | - | 29/08/2023 | |
| Chairman | 50 | 31/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -5.71% | -50.04% | -27.02% | 1.21Cr | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,05100Cr | |
| +1.23% | -1.53% | +55.26% | +59.07% | 61TCr | |
| +0.04% | +2.58% | +32.96% | +88.75% | 45TCr | |
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | |
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | |
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | |
| -1.76% | +2.37% | -22.19% | -38.45% | 22TCr | |
| -1.42% | +0.80% | +22.81% | +60.77% | 20TCr | |
| -1.48% | +3.43% | +23.42% | +73.31% | 17TCr | |
| Average | -0.16% | -0.09% | +20.31% | +47.54% | 35.75TCr | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.57 1.37 1.27 1.17 2.2 2.25 15.13 5.95 74.01 5.89 5.76 254.79 | 195.14 2.03 1.77 1.63 1.51 2.84 2.9 19.53 7.68 95.57 7.61 7.44 329 |
| Net income | -7.97Cr -8L -7L -7L -6L -11.59L -11.85L -79.75L -31.37L -3.9Cr -31.07L -30.39L -13Cr | -11Cr -11.19L -10L -9L -8L -15.68L -16.03L -1.08Cr -42.42L -5.28Cr -42.03L -41.1L -18Cr |
| Net Debt | 3.73Cr 4L 3L 3L 3L 5L 6L 37.32L 14.68L 1.83Cr 14.54L 14.22L 6.29Cr | 37Cr 38.24L 33.42L 30.84L 28.43L 53.58L 54.77L 3.69Cr 1.45Cr 18Cr 1.44Cr 1.4Cr 62Cr |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | ₹33.00 | -0.51% | 6,578 |
| 16/26/16 | ₹33.17 | -1.81% | 7,791 |
| 15/26/15 | ₹33.78 | +1.11% | 2,551 |
| 14/26/14 | ₹33.41 | -1.88% | 25,096 |
| 13/26/13 | ₹34.05 | -2.71% | 7,219 |
- Stock Market
- Stocks
- PHARMAID Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
